• ACVC Callout
News
ICViewExpert PerspectivesMedical World NewsVideosWebinars
Conference
Infection Control TodaySupplements And Featured Publications
CME/CEJob BoardPartnersSponsoredWhitepapers
Print SubscriptioneNewsletter
Educator of the Year Nomination FormEducator of the Year Official RulesEducator of the Year
Advanced Technology
Bug of the Month
COVID-19
Environmental Services
HAIs
Hand Hygiene
Long-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Prevention
Sterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • Expert Perspectives on Personal Protection Guidelines and Standardization Practices
  • Bug of the Month
Advanced Technology
Bug of the Month
COVID-19
Environmental Services
HAIs
Hand Hygiene
Long-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Prevention
Sterile Processing
Surface Disinfection
Vascular Access
    • News
    • Conference
Advertisement

Studying Link Between HIV and Drug Use Could Help Detection, Prevention Efforts

Feb 28, 2014
Article

Real-time social media like Twitter could be used to track HIV incidence and drug-related behaviors with the aim of detecting and potentially preventing outbreaks, a new UCLA-led study shows.

The study, published in the peer-reviewed journal Preventive Medicine, suggests it may be possible to predict sexual risk and drug use behaviors by monitoring tweets, mapping where those messages come from and linking them with data on the geographical distribution of HIV cases. The use of various drugs had been associated in previous studies with HIV sexual risk behaviors and transmission of infectious disease.

"Ultimately, these methods suggest that we can use 'big data' from social media for remote monitoring and surveillance of HIV risk behaviors and potential outbreaks," says Sean Young, assistant professor of family medicine at the David Geffen School of Medicine at UCLA and co-director of the Center for Digital Behavior at UCLA.

Founded by Young, the new interdisciplinary center brings together academic researchers and private sector companies to study how social media and mobile technologies can be used to predict and change behavior.

Other studies have examined how Twitter can be used to predict outbreaks of infections like influenza, said Young, who is also a member of the UCLA Center for Behavioral and Addiction Medicine; UCLA's Center for HIV Identification, Prevention and Treatment Services; and the UCLA AIDS Institute. "But this is the first to suggest that Twitter can be used to predict people's health-related behaviors and as a method for monitoring HIV risk behaviors and drug use," he says.
 
For the study, researchers collected more than 550 million tweets between May 26 and Dec. 9, 2012, and created an algorithm to find words and phrases in them suggesting drug use or potentially risky behaviors, such as "sex" or "get high." They then plotted those tweets on a map to discover where they originated, running statistical models to see if these were areas where HIV cases had been reported.

The algorithm captured 8,538 tweets indicating sexually risky behavior and 1,342 suggesting stimulant drug use. The geographical data on HIV cases to which researchers linked the tweets came from AIDSVu.org, an interactive online map that illustrates the prevalence of HIV in the U.S.; this mapping data was from 2009.

The states with the largest proportion of geo-located tweets, both general as well as HIV-related, were California (9.4 percent), Texas (9.0 percent), New York (5.7 percent) and Florida (5.4 percent). On a per capita basis, the largest raw number of HIV riskrelated tweets came from the District of Columbia, Delaware, Louisiana and South Carolina. States with the highest per capita rate of tweets were Utah, North Dakota and Nevada.

When the researchers linked the tweets to data on HIV cases, they found a significant relationship between those indicating risky behavior and counties where the highest numbers of HIV cases were reported.

Based on this study, the researchers conclude that it is possible to collect "big data" on real-time social media like Twitter about sexual and drug use behaviors, create a map of where the tweets are occur and use this information to understand and possibly predict where HIV cases and drug use occur.

The study's main weakness, the researchers say, is that the HIV data comes from 2009, so in order to test if this approach can be used to predict future behaviors and outbreaks there is a need for a "gold standard" of frequently updated data. In this way, tweets can be accessed instantly to compare them with disease outbreaks.

The study does however demonstrate the feasibility of using real-time social networking to identify and map HIV risk-related communications and link them to national HIV data, the researchers write.

"This study was designed to call for future research to understand the potential cost-effectiveness of this approach and to refine methods of using real-time social networking data for HIV and public health prevention and detection," they conclude.

Caitlin Rivers and Bryan Lewis of Virginia Tech co-authored the study.

A grant from the National Institutes of Mental Health (K01 MH09884) funded the study.

Source: UCLA 

Related Videos
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Association for the Health Care Environment (Logo used with permission)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
mRNA technology  (Adobe Stock 485886181 by kaptn)
Ambassador Deborah Birx, MD
Woman lying in hospital bed (Adobe Stock, unknown)
Photo of a model operating room. (Photo courtesy of Indigo-Clean and Kenall Manufacturing)
GIANTmicrobes at the 2023 APIC Annual Conference and Exhibition.  (Photo by the author)
Related Content

Poll: What Minimum Educational Requirement Should Infection Preventionists Have?

September 25th 2023

How to Prepare For Possible “Tripledemic” of RSV, Influenza, and SARS-CoV-2

September 25th 2023

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023

Poll: What Minimum Educational Requirement Should Infection Preventionists Have?

September 25th 2023

How to Prepare For Possible “Tripledemic” of RSV, Influenza, and SARS-CoV-2

September 25th 2023

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023

Poll: What Minimum Educational Requirement Should Infection Preventionists Have?

September 25th 2023

How to Prepare For Possible “Tripledemic” of RSV, Influenza, and SARS-CoV-2

September 25th 2023

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023
Related Content
Advertisement

(Adobe Stock FILE #:  56169337 by thinglass)

Poll: What Minimum Educational Requirement Should Infection Preventionists Have?

September 25th 2023
Article

Many infection preventionists (IPs) disagree on the minimum requirement to have the IP position. Let Infection Control Today know your opinion. Answer this poll, and send your thoughts to Senior Editor Tori Whitacre Martonicz at tmartonicz@mjhlifesciences.com.


Influenza, RSV, and COVID-19 (AdobeStock_249346161, AdobeStock_538653843,AdobeStock_471755796)

How to Prepare For Possible “Tripledemic” of RSV, Influenza, and SARS-CoV-2

September 25th 2023
Article

The interaction between the respiratory viruses SARS-CoV-2, influenza, and RSV, poses ongoing challenges. Personal protective measures, testing, and vaccination are critical components of our strategy to mitigate the impact of these viruses.


weekly rounds with infection control today

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023
Article

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending September 24, 2023.


NIH Announces HIV Vaccine Clinical Trial Begins

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023
Article

A new preventative vaccine has been developed incorporating technology funded by the NIH since 2004. The trials will be conducted in the United States and South Africa.


Vial of COVID-19 vaccine, bottle for injection with syringe.  (Adobe Stock 331786954 by myskin)

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023
Article

Randomized controlled trials show masks are effective. With COVID-19, even one mistake in protective gear usage could lead to infection and obscure results.


In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023
Article

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News